August 24, 2020 -- Harbour Biomed (HBM) and Vir Biotechnology have partnered to research and develop novel immuno-oncology and infectious disease therapies.
The partnership will leverage the scientific expertise at both companies in order to develop immunotherapies for patients with cancer and infectious disease. It will also utilize HBM's Harbour Mice technology to generate antibodies for the experiments.